公开(公告)号：IL311965A

公开(公告)日：2024-06-01

申请号：IL31196524

申请日：2024-04-07

Applicant: DEKA PRODUCTS LP ,  ANDREWS RICHARD E ,  BIBEAU TRAVIS G ,  BOWDEN SCOTT R ,  BRADLEY MARGARET B ,  CANNAN DAVID D B ,  GLOEB MCDONALD ROBERT G ,  JACOBSON STUART A ,  JOHNSON HANS E ,  LOPRIORE DOMINIC P ,  MOREAU TIMOTHY D ,  NAEEM ALDEN S ,  NARO TREVOR M ,  NORRIS MATTHEW A ,  REMEC ANDREW G ,  SIMM DAVID A ,  VIOLETTE KEITH D

Inventor： ANDREWS RICHARD E ,  BIBEAU TRAVIS G ,  BOWDEN SCOTT R ,  BRADLEY MARGARET B ,  CANNAN DAVID D B ,  GLOEB-MCDONALD ROBERT G ,  JACOBSON STUART A ,  JOHNSON HANS E ,  LOPRIORE DOMINIC P ,  MOREAU TIMOTHY D ,  NAEEM ALDEN S ,  NARO TREVOR M ,  NORRIS MATTHEW A ,  REMEC ANDREW G ,  SIMM DAVID A ,  VIOLETTE KEITH D

IPC: F16H25/20

Abstract: A system and method to enable treatment through cell therapy. The system can enable cell injection such as, for example, injecting beta cells/islets, cartilage cells, fat cells, and others. The system and method ensure that the delivery rate and delivered volume of the material pumped through a tube and into the injection needle is consistent over the course of the start-operation-stop process from run to run. The system and method can automatically stop delivery and alarm if an occlusion is detected during delivery.